|
🐜
|
Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine in children aged 6–17 years: a preliminary report of COV006, a phase 2 single-blind, randomised, controlled trial
72 auth.
Grace Li,
F. Cappuccini,
Natalie Marchevsky,
P. Aley,
R. Aley,
R. Anslow,
S. Bibi,
K. Cathie,
E. Clutterbuck,
S. Faust,
S. Feng,
P. Heath,
S. Kerridge,
Alice Lelliott,
Y. Mujadidi,
...
K. Ng,
S. Rhead,
H. Roberts,
H. Robinson,
M. Roderick,
Nisha Singh,
David J. Smith,
M. Snape,
R. Song,
Karly Tang,
Andy Yao,
Xinxue Liu,
T. Lambe,
A. Pollard,
J. Aboagye,
W. Ambihapathy,
J. Baker,
ER Beales,
A. Boon,
R. Brampton,
NM Branch,
R. Cooper,
E. Cornish,
S. Cuevas-Asturias,
Z. Dános,
S. Davies,
L. de Luna George,
R. Drury,
A. Flaxman,
J. Fowler,
E. Galiza,
L. Godfrey,
L. Haskell,
K. Hillson,
Clifford T. Hultin,
S. Koleva,
E. Lees,
R. Mabbett,
J. Muller,
Aps Munro,
A. Oliver,
Daniel R Owens,
J. Pearce,
M. Rajan,
H. Ratcliffe,
I. Rowbotham,
S. Salter,
H. Sanders,
S. Sapuan,
H. Sharpe,
E. Sheehan,
N. Sutton,
G. Thaygaraja,
S. Thomson-Hill,
M. Ulaszewska,
D. Woods,
Bristol Clinical Research Nurse Team
|
4 |
2022 |
4
🐜
|
